Private Advisor Group LLC Has $552,000 Stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Private Advisor Group LLC reduced its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 3.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,841 shares of the company’s stock after selling 1,344 shares during the period. Private Advisor Group LLC’s holdings in BlackRock Health Sciences Term Trust were worth $552,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Brown Lisle Cummings Inc. lifted its stake in shares of BlackRock Health Sciences Term Trust by 6.2% in the third quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock valued at $578,000 after buying an additional 2,128 shares in the last quarter. Sanctuary Advisors LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust in the 2nd quarter worth about $3,179,000. Quarry LP lifted its position in BlackRock Health Sciences Term Trust by 304.9% in the 2nd quarter. Quarry LP now owns 98,886 shares of the company’s stock valued at $1,519,000 after acquiring an additional 74,463 shares in the last quarter. Almitas Capital LLC lifted its position in BlackRock Health Sciences Term Trust by 89.3% in the 2nd quarter. Almitas Capital LLC now owns 1,761,943 shares of the company’s stock valued at $27,063,000 after acquiring an additional 831,025 shares in the last quarter. Finally, Sessa Capital IM L.P. boosted its stake in BlackRock Health Sciences Term Trust by 27.1% during the 2nd quarter. Sessa Capital IM L.P. now owns 1,853,022 shares of the company’s stock valued at $28,462,000 after purchasing an additional 395,288 shares during the last quarter.

BlackRock Health Sciences Term Trust Price Performance

Shares of BlackRock Health Sciences Term Trust stock opened at 15.79 on Monday. BlackRock Health Sciences Term Trust has a 52 week low of 13.25 and a 52 week high of 16.59. The business has a 50 day moving average price of 15.82 and a 200-day moving average price of 15.50.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently declared a monthly dividend, which was paid on Thursday, October 31st. Investors of record on Tuesday, October 15th were given a $0.176 dividend. This represents a $2.11 dividend on an annualized basis and a yield of 13.37%. The ex-dividend date was Tuesday, October 15th.

Insider Buying and Selling at BlackRock Health Sciences Term Trust

In other news, major shareholder Saba Capital Management, L.P. bought 15,455 shares of BlackRock Health Sciences Term Trust stock in a transaction dated Thursday, September 19th. The stock was purchased at an average price of 16.14 per share, for a total transaction of 249,443.70. Following the purchase, the insider now directly owns 20,601,568 shares in the company, valued at 332,509,307.52. The trade was a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last three months, insiders have purchased 99,630 shares of company stock worth $1,585,113.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.